Catalog Number：IRPA2302
SARS-CoV-2 (COVID-19) Spike Protein S1-NTD antibody
Application
Reactivity Virus
| REACTIVITY | Virus |
|---|---|
| SENSITIVITY | - |
| MW | 180-360 |
| SOURCE | Rabbit-IgG |
Product Includes
-
Application Dilution
Western Blot 1:2000 – 1:15000
Immunofluorescence 1:500 – 1:1000
Neutralizing Reported in the literature, not verified in house.
Immunofluorescence 1:500 – 1:1000
Neutralizing Reported in the literature, not verified in house.
Storage
Long time storage is recommended at -20°C
PBS (Ph7.4), 20% Glycerol. 0.025% ProClin 300 was added as a preservative
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user
PBS (Ph7.4), 20% Glycerol. 0.025% ProClin 300 was added as a preservative
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user
Specificity / Sensitivity
-
Source / Immunogen
-
-
IRPA2302 anti-SARS-CoV-2 (COVID-19) Spike Protein S1-NTD antibody WB image
Western blot analysis of SARS-CoV-2 (COVID-19) Spike Protein S1-NTD antibody.
SARS-CoV-2 (COVID-19) Spike protein was separated on SDS-PAGE gels under reducing conditions. After transferring the proteins to onto NC membranes.
Proteins at 0.1 μg per lane.